Synvitrobio wins $1M DARPA Phase II SBIR

Cyclotron Road innovator Zach Sun

Cyclotron Road innovator Zach Sun

Synvitrobio, Inc. led by Cyclotron Road innovator Zachary Sun was recently awarded a Phase II DARPA SBIR grant. The two-year, $1,000,000 grant will support Synvitrobio as it looks to expand development of a next-generation cell-free platform that allows for rapid, low-cost, high-throughput, and reproducible prototyping of complex biomolecular networks that emulate the in vivo environment.

Congratulations to Zach and Synvitrobio!